SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-22-000030
Filing Date
2022-08-05
Accepted
2022-08-05 16:06:38
Documents
80
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrtx-20220630.htm   iXBRL 10-Q 1743871
2 EX-10.1 a2022q210-qexhibit101.htm EX-10.1 1655703
3 EX-31.1 a2022q210-qexhibit311.htm EX-31.1 10833
4 EX-31.2 a2022q210-qexhibit312.htm EX-31.2 10831
5 EX-32.1 a2022q210-qexhibit321.htm EX-32.1 6404
11 GRAPHIC image_0.jpg GRAPHIC 162659
12 GRAPHIC vrtx-20220630_g1.gif GRAPHIC 10746
  Complete submission text file 0000875320-22-000030.txt   10050523

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20220630.xsd EX-101.SCH 40808
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20220630_cal.xml EX-101.CAL 79358
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20220630_def.xml EX-101.DEF 256819
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20220630_lab.xml EX-101.LAB 550571
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20220630_pre.xml EX-101.PRE 391669
74 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20220630_htm.xml XML 1619675
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 221140805
SIC: 2834 Pharmaceutical Preparations